<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0011010'>Chronic</z:hpo> ocular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is a rare form of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of the eye in patients with carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (CAO) </plain></SENT>
<SENT sid="1" pm="."><plain>The early and often asymptomatic stage of <z:hpo ids='HP_0011010'>chronic</z:hpo> ocular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is referred to as <z:e sem="disease" ids="C0277919" disease_type="Disease or Syndrome" abbrv="">venous stasis</z:e> <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (VSR) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to gain insight into the prevalence, cause, and outcome of VSR in patients with symptomatic CAO </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In 110 patients with symptomatic CAO, we prospectively investigated the frequency of VSR, the association between the presence of VSR and impaired cerebral blood flow, and the proportion of patients who developed clinically manifest <z:hpo ids='HP_0011010'>chronic</z:hpo> ocular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> of the anterior eye segment or <z:hpo ids='HP_0000618'>blindness</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: At study entry, VSR was found in 32 patients (29%; 95% CI, 21 to 38), particularly in those with symptoms classically associated with a hemodynamic cause, such as limb <z:mp ids='MP_0000745'>shaking</z:mp> (relative risk, 2.4; 95% CI, 1.0 to 5.9) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with VSR had lower pulsatility indexes in the ophthalmic artery in case of reversed flow, lower cerebral <z:chebi fb="97" ids="29325">CO2</z:chebi> reactivity, and lower cerebropetal blood flow than patients without VSR </plain></SENT>
<SENT sid="6" pm="."><plain>On follow-up (mean, 29 months), clinically manifest <z:hpo ids='HP_0011010'>chronic</z:hpo> ocular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> developed in 4 patients (annual rate, 1.5%; 95% CI, 0.4 to 3.8); it tended to occur more often in patients in whom VSR was present at study entry (relative risk, 7.3; 95% CI, 0.8 to 68) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: One third of patients with symptomatic CAO has VSR on ophthalmoscopy </plain></SENT>
<SENT sid="8" pm="."><plain>VSR is associated with an impaired flow state of the brain </plain></SENT>
<SENT sid="9" pm="."><plain>Development of clinically manifest <z:hpo ids='HP_0011010'>chronic</z:hpo> ocular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is rare </plain></SENT>
</text></document>